Clinical Trials on Melanoma, Uveal Metastatic in Norway
Total 241 results
-
Oslo University HospitalCompleted
-
Novartis PharmaceuticalsTerminatedUveal MelanomaUnited States, Australia, France, Netherlands, Spain, Norway
-
Haukeland University HospitalHoffmann-La Roche; Norwegian Cancer SocietyCompleted
-
Steinar AamdalTerminatedMetastatic Malignant MelanomaNorway
-
Haukeland University HospitalNorwegian Cancer Society; The Norwegian Melanoma GroupTerminatedMetastatic Malignant Melanoma | Unresectable Malignant MelanomaNorway
-
Clavis PharmaCompletedNeoplasm Metastasis | Malignant MelanomaUnited States, Norway, Sweden
-
Melanoma and Skin Cancer Trials LimitedUniversity of Oxford; Trans Tasman Radiation Oncology GroupActive, not recruitingMetastatic MelanomaNorway, Australia, United Kingdom
-
Ultimovacs ASAOslo University HospitalActive, not recruiting
-
Oslo University HospitalCompleted
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
European Organisation for Research and Treatment...TerminatedMetastatic Cancer | Melanoma (Skin)France, Norway, Belgium, Netherlands, United Kingdom, Austria, Czech Republic, Germany, Italy, Portugal, Switzerland
-
Oslo University HospitalActive, not recruitingMalignant MelanomaNorway
-
University Hospital of North NorwayCompletedMelanoma (Skin) | Actinic Keratoses | Non-melanoma Skin CancerNorway
-
Merck Sharp & Dohme LLCTerminatedAdvanced/Metastatic MelanomaUnited States, Australia, Chile, France, Germany, Israel, Italy, Korea, Republic of, Norway, South Africa, Spain
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Clavis PharmaCompletedMalignant MelanomaUnited States, Sweden, Norway
-
Haukeland University HospitalBerGenBio ASAActive, not recruiting
-
Oslo University HospitalCompletedEarly Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma PatientsMelanoma | ComplicationNorway
-
Oslo University HospitalThe Research Council of NorwayCompleted
-
University Hospital of North NorwayUniversity of Tromso; The Research Council of NorwayCompleted
-
Lytix Biopharma ASLaboratory Corporation of America; OWLActive, not recruitingAdvanced MelanomaUnited States, Spain, France, Norway
-
Targovax OyCompletedAdvanced or Unresectable Melanoma Progressing After PD1 BlockadeUnited States, Norway
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruitingMelanoma Stage IvAustralia, Norway
-
Bristol-Myers SquibbCompletedUnresectable Stage III or IV Malignant MelanomaUnited States, Peru, Norway, Italy, Sweden, Denmark, Israel
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMetastatic Cancer | Melanoma (Skin)United States
-
GlaxoSmithKlineTerminatedMelanomaNorway, Argentina, Greece
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Norway, Belgium, United Kingdom, Germany, Austria, Portugal, Italy
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Advanced Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedUveitis | Macular Edema | Anterior Uveitis | Iridocyclitis | IritisNorway
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)Italy, France, Spain, Switzerland, United Kingdom, Belgium, Australia, Norway, Poland, Finland, Netherlands, Germany, Israel, Denmark, Serbia, Estonia, Portugal, Russian Federation
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Helse Stavanger HFUnknownMetastatic Pancreatic CancerNorway
-
Bristol-Myers SquibbCompletedMelanomaItaly, Netherlands, Russian Federation, Czechia, Hungary, Ireland, Norway, Spain, Switzerland, Austria, Germany, Denmark, France, Belgium, United Kingdom, United States
-
Norwegian University of Science and TechnologyThe Royal Norwegian Ministry of HealthCompletedMelanoma | Breast Neoplasms | Lung Neoplasms | Neoplasm MetastasisNorway
-
Norwegian University of Science and TechnologyThe Royal Norwegian Ministry of HealthWithdrawnMelanoma | Breast Neoplasms | Lung Neoplasms | Neoplasm MetastasisNorway
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Ultimovacs ASACompletedMalignant MelanomaUnited States, Belgium, United Kingdom, Norway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
National Cancer Institute (NCI)Active, not recruitingUnresectable Cutaneous Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Mucosal Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Children's Oncology... and other collaboratorsActive, not recruitingMelanoma (Skin)United States, Canada, Australia, South Africa
-
Haukeland University HospitalHelse Stavanger HFUnknownQuality of Life | MetastasisNorway
-
National Cancer Institute (NCI)Active, not recruitingStage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Unresectable MelanomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
AstraZenecaCompletedMelanomaSweden, United States, Brazil, Czech Republic, France, Spain, United Kingdom, Germany, Norway, Hungary, Netherlands, Switzerland
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable MelanomaUnited States
-
Oslo University HospitalRecruitingMetastatic Colorectal Cancer | Cholangiocarcinoma | Pancreas AdenocarcinomaNorway
-
AstraZenecaCompletedMetastatic Breast CancerNorway